Journals / MN Oftalmoloji / 2018 / Cilt: 25 - Sayı: 0

Iatrogenic Dry Eye Disease

İatrojenik Kuru Göz Hastalığı

Pages
13–29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The first step of treatment is the elimination of causative factors and understanding the role of the treatments on dry eye etiopathogenesis is extremely important.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In recent years, the increase in frequency of topical and systemic treatment, stand out of quality of life and comfort of the pa- tients after surgery and increased cosmetic interventions, have aroused an attention on iatrogenic causes of dry eyes .
📊
Key Findings & Data:Due to this awareness, iatrogenic dry eye has been handled in DEWS II report in a detailed separate section.
💡
Conclusion & Impact:The first step of treatment is the elimination of causative factors and understanding the role of the treatments on dry eye etiopathogenesis is extremely important.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In recent years, the increase in frequency of topical and systemic treatment, stand out of quality of life and comfort of the pa- tients after surgery and increased cosmetic interventions, have aroused an attention on iatrogenic causes of dry eyes . Due to this awareness, iatrogenic dry eye has been handled in DEWS II report in a detailed separate section. The first step of treatment is the elimination of causative factors and understanding the role of the treatments on dry eye etiopathogenesis is extremely important.

Özet

Son yıllarda topikal ve sistemik tedavilerin kullanım sıklığının artması, yapılan cerrahiler sonrası hastaların hayat kalitele- rinin, konforunun öne çıkması ve artan kozmetik girişimler, dikkatlerin iatrojenik kuru göz üzerinde yoğunlaşmasına neden olmuştur. Bu farkındalık Kuru Göz Çalıştayı II Raporu’nda iatrojenik kuru gözün ayrı ve ayrıntılı bir şekilde ele alınmasına yol açmıştır. En iyi tedavi yöntemi öncelikle etkenlerin ortadan kaldırılması olduğundan, uyguladığımız tedavilerin kuru göz etyopatogenezindeki rollerini anlamak son derece önem taşımaktadır.

🔖

Cite This Article

GÜRDAL, C., AVARİSLİ, N. A. (2018). Iatrogenic Dry Eye Disease. MN Oftalmoloji, Cilt: 25 - Sayı: 0, 13–29. https://ajindex.com/articles/295428

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. TFOS DEWS II iatrogenic report 2017.
  2. Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medication in causing dry eye. J Ophthalmol 2012; 2012:285851. Schein OD, Hochberg MC, Munoz B, et al. Dry eye and dry mouth in the elderly: a population-based as- sessment. Arch Intern Med 1999;159(12):1359e63. Schaumberg DA. Dana R. Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: esti- mates from the Physicians’ Health Studies. Arch Ophthalmol 2009;127(6):763-8
  3. Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 2014;157(4):799e806. Creuzot-Garcher C. La secheresse oculaire li ee aux medications syst emiques. J Fr Ophtalmol 2009;32 (1):64e70. Jaanus SD. Ocular side effects of selected systemic drugs. Optom Clin 1992;2(4):73e96. Han SB, Yang HK, Hyon JY, Wee WR. Association of dry eye disease with psychiatric or neurological dis- orders in elderly patients. Clin Interv Aging 2017; 12:785-792.
  4. Krenzer KL, Dana MR, Ullman MD, et al. Effect of an- drogen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85 (12):4874e82. Kim JH, Kim JH, et al. Oral alcohol administration dis- turbs tear film and ocular surface. Ophthalmology 2012;119(5):965e71. Maino DM, Tran S, Mehta F. Side effects of chemot - he rapeuticoculo-toxic agents: a review. Clin Eye Vis Care 2000;12(3-4):113-7.
  5. Samarawickrama C, Chew S, Watson S. Retinoic acid and the ocular surface. Surv Ophthalmol 2015;60(3): 183-95.
  6. Brzezinski P, Borowska K, Chiriac A, Smigielski J. Ad - ver se effects of isotretinoin: A large, retrospective re- view. Dermatol Ther 2017 Jul;30(4).doi:10.1111/ dth.12483. Fraunfelder FT. Sciubba JJ. Mathers WD. Review Artic le The Role of Medications in Causing Dry Eye. J Ophthalmol 2012;2012:285851. Labbe A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear film osmolarity inpatients treated for glaucoma or ocular hypertension. Cornea 2012;31(9):994e9. Corrales RM, de Paiva CS, Li DQ, et al. Entrapment of conjunctival goblet cells by desiccation-induced cornification. Investig Ophthalmol Vis Sci 2011;52 (6): 3492e9. Jaenen N, Baudouin C, Pouliquen P, et al. Ocular symptoms and signs with preserved and preservative- free glaucoma medications. Eur J Ophthalmol 2007; 17(3):341e9. Actis AG, Rolle T. Ocular Surface Alterations and Topi - cal Antiglaucomatous Therapy: A Review Open Opht - hal mol J 2014;8:67-72. Baudouin C Lab